S&P 500   4,464.05
DOW   35,281.40
QQQ   366.24
Biden and House Democrats hope to make curbing 'junk fees' a winning issue in 2024
Laser breakthrough could send stock soaring 2,467% (Ad)
Yes, inflation is down. No, the Inflation Reduction Act doesn't deserve the credit
Stock market today: Asia follows Wall Street lower after US data revive fears about rate hike
Laser breakthrough could send stock soaring 2,467% (Ad)
Illinois governor signs ban on firearms advertising allegedly marketed to kids and militants
Don't expect quick fixes in 'red-teaming' of AI models. Security was an afterthought
Why 2023 Could Kick Off a "Cash Frenzy" in Stocks (Ad)
US Steel rejects a $7.3 billion offer from rival Cleveland-Cliffs; considers alternatives
Don't expect quick fixes in 'red-teaming' of AI models. Security was an afterthought
S&P 500   4,464.05
DOW   35,281.40
QQQ   366.24
Biden and House Democrats hope to make curbing 'junk fees' a winning issue in 2024
Laser breakthrough could send stock soaring 2,467% (Ad)
Yes, inflation is down. No, the Inflation Reduction Act doesn't deserve the credit
Stock market today: Asia follows Wall Street lower after US data revive fears about rate hike
Laser breakthrough could send stock soaring 2,467% (Ad)
Illinois governor signs ban on firearms advertising allegedly marketed to kids and militants
Don't expect quick fixes in 'red-teaming' of AI models. Security was an afterthought
Why 2023 Could Kick Off a "Cash Frenzy" in Stocks (Ad)
US Steel rejects a $7.3 billion offer from rival Cleveland-Cliffs; considers alternatives
Don't expect quick fixes in 'red-teaming' of AI models. Security was an afterthought
S&P 500   4,464.05
DOW   35,281.40
QQQ   366.24
Biden and House Democrats hope to make curbing 'junk fees' a winning issue in 2024
Laser breakthrough could send stock soaring 2,467% (Ad)
Yes, inflation is down. No, the Inflation Reduction Act doesn't deserve the credit
Stock market today: Asia follows Wall Street lower after US data revive fears about rate hike
Laser breakthrough could send stock soaring 2,467% (Ad)
Illinois governor signs ban on firearms advertising allegedly marketed to kids and militants
Don't expect quick fixes in 'red-teaming' of AI models. Security was an afterthought
Why 2023 Could Kick Off a "Cash Frenzy" in Stocks (Ad)
US Steel rejects a $7.3 billion offer from rival Cleveland-Cliffs; considers alternatives
Don't expect quick fixes in 'red-teaming' of AI models. Security was an afterthought
S&P 500   4,464.05
DOW   35,281.40
QQQ   366.24
Biden and House Democrats hope to make curbing 'junk fees' a winning issue in 2024
Laser breakthrough could send stock soaring 2,467% (Ad)
Yes, inflation is down. No, the Inflation Reduction Act doesn't deserve the credit
Stock market today: Asia follows Wall Street lower after US data revive fears about rate hike
Laser breakthrough could send stock soaring 2,467% (Ad)
Illinois governor signs ban on firearms advertising allegedly marketed to kids and militants
Don't expect quick fixes in 'red-teaming' of AI models. Security was an afterthought
Why 2023 Could Kick Off a "Cash Frenzy" in Stocks (Ad)
US Steel rejects a $7.3 billion offer from rival Cleveland-Cliffs; considers alternatives
Don't expect quick fixes in 'red-teaming' of AI models. Security was an afterthought
NYSE:KVUE

Kenvue (KVUE) Stock Forecast, Price & News

$23.72
+0.35 (+1.50%)
(As of 08/11/2023 08:48 PM ET)
Compare
Today's Range
$23.25
$23.80
50-Day Range
$23.35
$26.55
52-Week Range
$22.49
$27.80
Volume
46.06 million shs
Average Volume
8.21 million shs
Market Capitalization
$45.42 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$28.11

KVUE stock logo

About Kenvue (NYSE:KVUE) Stock

Kenvue Inc. operates as a consumer health company worldwide. The company operates through three segments: Self Care, Skin Health and Beauty, and Essential Health. The Self Care segment offers cough, cold and allergy, pain care, digestive health, smoking cessation, and other products under the Tylenol, Nicorette, and Zyrtec brands. The Skin Health and Beauty segment provides face and body care, hair care, and sun and other care products under the Neutrogena, Aveeno, and OGX brand names. The Essential Health segment offers oral and baby, women's health, and wound care products under the Listerine, Johnson's, Band-Aid, and Stayfree brands. The company was incorporated in 2022 and is headquartered in Skillman, New Jersey. Kenvue Inc. operates as a subsidiary of Johnson & Johnson.

KVUE Price History

KVUE Stock News Headlines

His system isolated NVIDIA - Here's His Next Buy.
Most investors don't know the truth about A.I. 50-year Wall Street Insider Marc Chaikin reveals what you should be doing to profit. Learn more here.
KVUE Aug 2023 23.500 call
Is Kenvue Stock a Buy After Earnings?
Kenvue To Join S&P 500
Seven millionaires secretly enable market shock?
A fraud expert to the FBI just shared a surprising new prediction. Own stocks? Watch it now.
Kenvue Unusual Options Activity
Investors Buy High Volume of Kenvue Call Options (NYSE:KVUE)
KVUE Aug 2023 17.500 call
Johnson & Johnson launches Kenvue exchange offer
Johnson & Johnson Launches Exchange Offer To Separate Kenvue
What 10 Analyst Ratings Have To Say About Kenvue
See More Headlines
Receive KVUE Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Kenvue and its competitors with MarketBeat's FREE daily newsletter.

KVUE Company Calendar

Last Earnings
7/20/2023
Today
8/13/2023
Ex-Dividend for 9/7 Dividend
8/25/2023
Dividend Payable
9/07/2023
Next Earnings (Estimated)
10/19/2023
Fiscal Year End
12/31/2023

Industry, Sector and Symbol

Industry
Toilet preparations
Sub-Industry
N/A
Fax
N/A
Employees
22,200
Year Founded
N/A

Price Target and Rating

Average Stock Price Forecast
$28.11
High Stock Price Forecast
$30.00
Low Stock Price Forecast
$26.00
Forecasted Upside/Downside
+18.5%
Consensus Rating
Hold
Rating Score (0-4)
2.40
Research Coverage
10 Analysts

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
$14.95 billion
Book Value
$5.77 per share

Miscellaneous

Outstanding Shares
1,914,890,000
Free Float
N/A
Market Cap
$45.42 billion
Optionable
Not Optionable
Beta
N/A
Investing Strategies To Help Grow Your Retirement Income Cover

Need to stretch out your 401K or Roth IRA plan? Use these time-tested investing strategies to grow the monthly retirement income that your stock portfolio generates.

Get This Free Report

Key Executives

  • Mr. Thibaut Mongon (Age 52)
    CEO & Director
    Comp: $1.91M
  • Mr. Paul Ruh (Age 55)
    Chief Financial Officer
    Comp: $862.45k
  • Mr. Carlton Lawson (Age 54)
    Group Pres of Europe, Middle East & Africa
    Comp: $1.16M
  • Ms. Kathleen M. Widmer (Age 61)
    Group Pres of North America & Latin America
    Comp: $815.39k
  • Ms. Ellie Bing Xie (Age 53)
    Group Pres of Asia Pacific
    Comp: $1.9M
  • Ms. Meredith Stevens (Age 60)
    Chief Operations Officer
  • Ms. Heather R. Howlett (Age 45)
    Chief Accounting Officer
  • Mr. Bernardo Tavares (Age 55)
    Chief Data & Technology Officer
  • Dr. Caroline Tillett (Age 51)
    Chief Scientific Officer
  • Mr. Matthew Orlando (Age 46)
    Gen. Counsel













KVUE Stock - Frequently Asked Questions

Should I buy or sell Kenvue stock right now?

10 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Kenvue in the last twelve months. There are currently 6 hold ratings and 4 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "hold" KVUE shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in KVUE, but not buy additional shares or sell existing shares.
View KVUE analyst ratings
or view top-rated stocks.

What is Kenvue's stock price forecast for 2023?

10 analysts have issued 12-month price objectives for Kenvue's stock. Their KVUE share price forecasts range from $26.00 to $30.00. On average, they predict the company's stock price to reach $28.11 in the next twelve months. This suggests a possible upside of 18.5% from the stock's current price.
View analysts price targets for KVUE
or view top-rated stocks among Wall Street analysts.

How have KVUE shares performed in 2023?

Kenvue's stock was trading at $26.50 at the beginning of 2023. Since then, KVUE shares have decreased by 10.5% and is now trading at $23.72.
View the best growth stocks for 2023 here
.

When is Kenvue's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Thursday, October 19th 2023.
View our KVUE earnings forecast
.

How were Kenvue's earnings last quarter?

Kenvue Inc. (NYSE:KVUE) posted its quarterly earnings data on Thursday, July, 20th. The company reported $0.32 EPS for the quarter, beating the consensus estimate of $0.30 by $0.02. The firm had revenue of $4.01 billion for the quarter, compared to the consensus estimate of $3.96 billion. The firm's quarterly revenue was up 5.4% compared to the same quarter last year.

How often does Kenvue pay dividends? What is the dividend yield for Kenvue?

Kenvue announced a quarterly dividend on Thursday, July 20th. Stockholders of record on Monday, August 28th will be paid a dividend of $0.20 per share on Thursday, September 7th. This represents a $0.80 dividend on an annualized basis and a yield of 3.37%. The ex-dividend date is Friday, August 25th.
Read our dividend analysis for KVUE
.

What ETFs hold Kenvue's stock?

ETFs with the largest weight of Kenvue (NYSE:KVUE) stock in their portfolio include Putnam Sustainable Leaders ETF (PLDR) and Renaissance IPO ETF (IPO).First Trust US Equity Opportunities ETF (FPX).

What guidance has Kenvue issued on next quarter's earnings?

Kenvue issued an update on its FY 2023 earnings guidance on Thursday, July, 20th. The company provided earnings per share (EPS) guidance of $1.26-$1.31 for the period, compared to the consensus EPS estimate of $1.23. The company issued revenue guidance of $15.73 billion-$15.88 billion, compared to the consensus revenue estimate of $15.74 billion.

When did Kenvue IPO?

(KVUE) raised $3.3 billion in an initial public offering (IPO) on Thursday, May 4th 2023. The company issued 151,200,000 shares at a price of $20.00-$23.00 per share. Goldman Sachs, J.P. Morgan, BofA Securities, Citigroup, Deutsche Bank Securities, BNP PARIBAS, HSBC, RBC Capital Markets and UBS Investment Bank acted as the underwriters for the IPO.

What is Kenvue's stock symbol?

Kenvue trades on the New York Stock Exchange (NYSE) under the ticker symbol "KVUE."

When does Kenvue's lock-up period expire?

Kenvue's lock-up period expires on Tuesday, October 31st. Kenvue had issued 172,812,560 shares in its public offering on May 4th. The total size of the offering was $3,801,876,320 based on an initial share price of $22.00. After the expiration of Kenvue's lock-up period, company insiders and major shareholders will be able to sell their shares of the company.

Who are Kenvue's major shareholders?

Kenvue's stock is owned by a number of institutional and retail investors. Top institutional shareholders include Capital International Investors (0.43%), BlackRock Inc. (0.33%), Capital World Investors (0.31%), Boston Partners (0.27%), JPMorgan Chase & Co. (0.24%) and Bank of New York Mellon Corp (0.22%).
View institutional ownership trends
.

How do I buy shares of Kenvue?

Shares of KVUE stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Kenvue's stock price today?

One share of KVUE stock can currently be purchased for approximately $23.72.

How much money does Kenvue make?

Kenvue (NYSE:KVUE) has a market capitalization of $45.42 billion and generates $14.95 billion in revenue each year.

How many employees does Kenvue have?

The company employs 22,200 workers across the globe.

How can I contact Kenvue?

The official website for the company is www.kenvue.com. The company can be reached via phone at (732) 524-0400.

This page (NYSE:KVUE) was last updated on 8/14/2023 by MarketBeat.com Staff

My Account -